Utility of Escherichia coli Nissle in maintaining disease remission in inflammatory bowel disease

被引:0
|
作者
Buldukoglu, Osman Cagin [1 ]
机构
[1] Univ Hlth Sci, Antalya Training & Res Hosp, Dept Gastroenterol, Antalya, Turkiye
关键词
ULCERATIVE-COLITIS;
D O I
10.15403/jgld-5578
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Utility of Escherichia coli Nissle in maintaining disease remission in inflammatory bowel disease Reply
    Pasta, Andrea
    Calabrese, Francesco
    Bodini, Giorgia
    [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2024, 33 (02)
  • [2] Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications
    Zhao, Zejing
    Xu, Shumin
    Zhang, Wangyang
    Wu, Danjun
    Yang, Gensheng
    [J]. Food and Function, 2022, 13 (11): : 5914 - 5924
  • [3] Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications
    Zhao, Zejing
    Xu, Shumin
    Zhang, Wangyang
    Wu, Danjun
    Yang, Gensheng
    [J]. FOOD & FUNCTION, 2022, 13 (11) : 5914 - 5924
  • [4] Escherichia coli Nissle 1917 ghosts alleviate inflammatory bowel disease in zebrafish
    Chen, Haojie
    Lei, Pengyu
    Ji, Hao
    Ma, Jiahui
    Fang, Yimeng
    Yu, Haiyang
    Du, Jiao
    Qu, Linkai
    Yang, Qinsi
    Luo, Li
    Zhang, Kun
    Wu, Wei
    Jin, Libo
    Sun, Da
    [J]. LIFE SCIENCES, 2023, 329
  • [5] The efficacy of methotrexate for maintaining remission in inflammatory bowel disease
    Fraser, AG
    Morton, D
    McGovern, D
    Travis, S
    Jewell, DP
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (04) : 693 - 697
  • [6] E. coli Nissle 1917 in the Treatment of Inflammatory Bowel Disease
    Schultz, Michael
    Butt, Grant
    [J]. PRACTICAL GASTROENTEROLOGY, 2010, 34 (03) : 11 - 19
  • [7] The role of Escherichia coli in inflammatory bowel disease
    Rhodes, Jonathan M.
    [J]. GUT, 2007, 56 (05) : 610 - 612
  • [8] Clinical use of E-coli Nissle 1917 in inflammatory bowel disease
    Schultz, Michael
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (07) : 1012 - 1018
  • [9] Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease
    Mirsepasi-Lauridsen, Hengameh Chloe
    Vallance, Bruce Andrew
    Krogfelt, Karen Angeliki
    Petersen, Andreas Munk
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2019, 32 (02)
  • [10] Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
    Kruis, W
    Fric, P
    Pokrotnieks, J
    Lukas, M
    Fixa, B
    Kascák, M
    Kamm, MA
    Weismueller, J
    Beglinger, C
    Stolte, M
    Wolff, C
    Schulze, J
    [J]. GUT, 2004, 53 (11) : 1617 - 1623